
FOLDRX PHARMACEUTICALS focuses on the discovery, development, and commercialization of small molecule therapeutics. The company became a wholly owned subsidiary of Pfizer Inc. in 2012.
Location: United States, Massachusetts, Cambridge
Total raised: $29M
Investors 1
Funding Rounds 1
Date | Series | Amount | Investors |
15.06.2010 | - | $29M | - |
Mentions in press and media 2
Date | Title | Description |
15.06.2010 | FoldRx Pharmaceuticals Closes $29M Financing Round | FoldRx Pharmaceuticals, Inc., a Cambridge, MA-based drug development company focusing on disease-modifying, small molecule therapeutics to treat diseases of protein misfolding and aggregation (amyloidosis), has closed a $29m financing round... |
13.08.2007 | Life sciences briefing: Monday, Aug. 13, 2007 | (UPDATED: See below.) Featured companies: FoldRx Pharmaceuticals, Ophthotech, Pevion Biotech, Restoration Robotics, Glide Pharma, Reliant Pharmaceuticals, Nanosphere, SurModics, BioFX Laboratories FoldRx Pharma to receive $22M against cysti... |